Pure Global AI
NCT06220942Recruiting

Tachycardia as an Indication for Prophylactic Phenylephrine Injection in Caesarean Section Under Spinal Anesthesia; an Observational Study

Ain Shams UniversityClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
Phenylephrine
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Ain Shams University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Oct 05, 2023
End date
May 01, 2024
Enrollment
80 participants
Primary outcome

Occurrence of Hypotension Avoidance of Hypotension Avoidance of Hypotension

Summary

The value of phenylephrine administration in response to tachycardia in preventing
 hypotension after spinal anesthesia in elective cesarean section.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06220942
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06220942 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.